Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,275.13 -30.91 (-0.58%) Dow
38,503.84 -349.02 (-0.90%) Nasdaq
16,957.50 -62.38 (-0.37%) Bitcoin USD
67,718.48 -169.42 (-0.25%) CMC Crypto 200
1,452.73 -31.96 (-2.15%)
AxoGen, Inc. (0HKD.L)
| Previous close | 6.64 |
| Open | 6.45 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 6.45 - 6.60 |
| 52-week range | 3.50 - 10.82 |
| Volume | |
| Avg. volume | 424 |
| Market cap | 2.469M |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
Showcasing Axogen’s Dedication to Fueling Ohio’s Biotechnology Sector GrowthALACHUA, Fla. and TAMPA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will celebrate the opening of its Axogen Processing Center (APC) with leaders of the Ohio community on June 12, 2024. APC is designed to process Avance Nerve Graft®, a regenerative peripheral nerve scaf
- GlobeNewswire
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft® on May 15, 2024. “Today’s milestone represents a significant step in our regulatory transition of Avance
- GlobeNewswire
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
ALACHUA, Fla. and TAMPA, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, chief executive officer, and president, will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference in Austin, TX, on Wednesday, May 29, 2024, at 3:40 p.m. CT / 4:40 p.m. ET. Webcast events can be accessed live through the
